Johnson & Johnson to Participate in Credit Suisse 2013 Health Care Conference

NEW BRUNSWICK, N.J., Nov. 5, 2013 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 2013 Health Care Conference on Tuesday, Nov. 12th, at The Phoenician, 6000 East Camelback Road, Scottsdale, AZ.  Dominic J. Caruso, Vice President, Finance & Chief Financial Officer, will represent the company in a session scheduled at 10:00 a.m. (Mountain Standard Time).

This broadcast will be available to interested investors and parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available shortly after the live webcast.

SOURCE Johnson & Johnson

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.